P. Ferrara

Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

M. Pariat, S. Carillo, C. Salvat, 1999, Molecular Biology Reports.

Multiple Degradation Pathways for Fos Family Proteins

C. Acquaviva, I. Jariel-Encontre, M. Piechaczyk, 2002, Annals of the New York Academy of Sciences.

Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.

C. Acquaviva, I. Jariel-Encontre, M. Piechaczyk, 2002, Biochemical pharmacology.

Degradation of cellular and viral Fos proteins.

C. Acquaviva, C. Salvat, I. Jariel-Encontre, 2001, Biochimie.

c-Fos Proto-Oncoprotein Is Degraded by the Proteasome Independently of Its Own Ubiquitinylation In Vivo

C. Acquaviva, I. Jariel-Encontre, M. Piechaczyk, 2003, Molecular and Cellular Biology.

The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression

C. Acquaviva, I. Jariel-Encontre, M. Piechaczyk, 2003, Oncogene.

Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G0-to-S phase transition

C. Acquaviva, C. Salvat, I. Jariel-Encontre, 2001, Oncogene.

Cellular and viral Fos proteins are degraded by different proteolytic systems

C. Acquaviva, C. Salvat, I. Jariel-Encontre, 2001, Oncogene.

beta-Endorphin: characteristics of binding sites in a neuroblastoma--glioma hybrid cell.

C. Li, P. Ferrara, R. Hammonds, 1981, Proceedings of the National Academy of Sciences of the United States of America.